NanoGhost
- Biotech or pharma, therapeutic R&D
NanoGhost develops a novel, highly selective, first-in-class drug targeting platform manufactured from the cell membrane of bone marrow-derived mesenchymal stem cells (BM-MSCs). This platform harnesses MSCs' natural tropism toward cancer.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}